Canada approved COVID-19 vaccine from Pfizer and BioNTech.
Canada on Wednesday officially approved the COVID-19 vaccine produced by Pfizer and BioNTech, days after UK became the first country to approve and roll it out.
In a statement, Health Canada said that Canada reached a critical milestone in its fight against the coronavirus disease with the authorization of the first coronavirus vaccine.
The COVID-19 vaccine, it added, underwent a fast-tracked review which concluded that it met strict safety, efficacy, and quality requirements for use in Canada.
Canada will start its vaccination rollout as early as next week — a seeming difficult challenge for a sparsely populated country with the world’s 2nd largest territory — with a portfolio of vaccine candidates that it argued was among the most diverse among large economies.
On Wednesday, a spokesperson for Pfizer’s Canadian unit said that Pfizer will supply Canada up to 76 million COVID-19 vaccine doses.
The agreement called for Canada to procure a minimum of 20 million COVID-19 vaccine doses with an option for 56 million more.
As more countries moved to authorize the coronavirus vaccine that was developed and produced in the West, the companies behind it were working to meet its production targets.
Vaccine makers BioNTech and Pfizer had presold around 600 million COVID-19 vaccine doses across the world, but these companies had produced only a fraction of that number so far.